AU4969700A - Melt granulation - Google Patents

Melt granulation

Info

Publication number
AU4969700A
AU4969700A AU49697/00A AU4969700A AU4969700A AU 4969700 A AU4969700 A AU 4969700A AU 49697/00 A AU49697/00 A AU 49697/00A AU 4969700 A AU4969700 A AU 4969700A AU 4969700 A AU4969700 A AU 4969700A
Authority
AU
Australia
Prior art keywords
melt granulation
granulation
melt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49697/00A
Inventor
Darja Fercej-Temeljotov
Andrej Golmajer
Milojka Mohar
Marko Opresnik
Mateja Salobir
Judita Sirca
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lek Pharmaceuticals dd
Original Assignee
Lek Pharmaceuticals and Chemical Co dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals and Chemical Co dd filed Critical Lek Pharmaceuticals and Chemical Co dd
Publication of AU4969700A publication Critical patent/AU4969700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
AU49697/00A 1999-05-19 2000-05-18 Melt granulation Abandoned AU4969700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI9900119A SI20244A (en) 1999-05-19 1999-05-19 Melt granulation
SIP-9900119 1999-05-19
PCT/SI2000/000013 WO2000069415A2 (en) 1999-05-19 2000-05-18 Melt granulation

Publications (1)

Publication Number Publication Date
AU4969700A true AU4969700A (en) 2000-12-05

Family

ID=20432471

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49697/00A Abandoned AU4969700A (en) 1999-05-19 2000-05-18 Melt granulation

Country Status (13)

Country Link
EP (1) EP1183013A2 (en)
AU (1) AU4969700A (en)
BG (1) BG106236A (en)
CZ (1) CZ20014133A3 (en)
EE (1) EE200100607A (en)
HR (1) HRP20010932A2 (en)
HU (1) HUP0201233A3 (en)
PL (1) PL351654A1 (en)
RU (1) RU2001134166A (en)
SI (1) SI20244A (en)
SK (1) SK16642001A3 (en)
WO (1) WO2000069415A2 (en)
YU (1) YU82001A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001263812B2 (en) * 2000-03-28 2004-09-23 Sandoz Ag Granulated particles with masked taste

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002239232A1 (en) * 2000-10-13 2002-05-21 Advancis Pharmaceutical Corporation Extended release erythromycin derivatives
DK1484056T3 (en) * 2002-02-21 2013-09-08 Otsuka Pharma Co Ltd Slow release compositions and processes for their preparation
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8219191A (en) * 1990-06-14 1992-01-07 Kalmo Enterprises, Inc. Stable aqueous drug suspensions
JP3265680B2 (en) * 1992-03-12 2002-03-11 大正製薬株式会社 Oral pharmaceutical composition
DE69332801T2 (en) * 1992-11-30 2004-01-29 Kv Pharm Co TASTE-MASKED PHARMACEUTICAL SUBSTANCES
IT1312058B1 (en) * 1999-04-09 2002-04-04 Pharmaplus S R L METHOD FOR MICRO-ENCAPSULATION OF MEDICATIONS.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001263812B2 (en) * 2000-03-28 2004-09-23 Sandoz Ag Granulated particles with masked taste

Also Published As

Publication number Publication date
SI20244A (en) 2000-12-31
CZ20014133A3 (en) 2002-03-13
EP1183013A2 (en) 2002-03-06
SK16642001A3 (en) 2002-05-09
HUP0201233A3 (en) 2003-10-28
BG106236A (en) 2002-08-30
RU2001134166A (en) 2003-08-27
PL351654A1 (en) 2003-05-19
HUP0201233A2 (en) 2002-08-28
EE200100607A (en) 2003-02-17
HRP20010932A2 (en) 2003-04-30
WO2000069415A2 (en) 2000-11-23
WO2000069415A3 (en) 2001-04-26
YU82001A (en) 2004-07-15

Similar Documents

Publication Publication Date Title
AU5586800A (en) Low melt encapsulation
AU1173201A (en) Skin-gripper
AU3092999A (en) Digital-timeshare-exchange
AU2678800A (en) Modified calycins
AU5967600A (en) Candystraw
AU4115400A (en) Short-circuiter
AU6335000A (en) Depthimeter
AU7514700A (en) Cyanopiperidines
AU6440900A (en) Homogentisate-dioxygenase
AU2023701A (en) Sketcher
AU2804600A (en) Arylaminoalkylamides
AU4997000A (en) Granulation process
AU4568900A (en) Improved can
AU2699800A (en) Organoceramics
AU4916900A (en) Benzofuranylsulfonates
AU6098300A (en) Follistatin-3
AU4561600A (en) Benzofuranylaminoalcohols
AU4969700A (en) Melt granulation
AU3656900A (en) Granulation method
AU1901801A (en) Glucofuranoses
AU6567400A (en) Substituted 2-imino-thiazolines
AU7303400A (en) Osseo-distractor
AU1915601A (en) Periotome
AU4435300A (en) Hula-hoop
AU2582200A (en) Windturbine

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase